Literature DB >> 1411289

Gastric emptying in infants with gastroesophageal reflux. Ultrasound evaluation before and after cisapride administration.

A Carroccio1, G Iacono, G Li Voti, G Montalto, F Cavataio, V Tulone, D Lorello, I Kazmierska, C Acierno, A Notarbartolo.   

Abstract

The present study aimed to evaluate gastric emptying in children with gastroesophageal reflux (GER) by means of real-time ultrasonography, on the basis of measurements of the cross-sectional area of the gastric antrum. Twelve children with GER were studied (seven males, five females; age range, 3-13 months) and compared with 12 normal control children (six males, six females; age range, 3-13 months). The diagnosis of GER was confirmed by 24-h esophageal pH-monitoring. The GER patients had a significantly greater antral area than the controls at 90, 105, and 120 min after eating a standard meal (cow's milk formula, 300 ml/m2 body surface area); in addition, final gastric emptying time was significantly greater in the patients than in the controls (145 +/- 36.9 versus 78.7 +/- 19.3 min; p less than 0.0025). After 8 weeks of treatment with cisapride (0.3 ml/kg, three times a day) 24-h esophageal pH-monitoring and ultrasonography studies were repeated in the patients. The total percentage reflux time was significantly lower (p less than 0.038), and ultrasonography showed a decreased antral area at all the various study times, with no significant difference between patients and controls; final gastric emptying time was also significantly lower than before treatment (p less than 0.009). Furthermore, in the GER patients there was a significant correlation between gastric emptying time and the sum of the various reflux times recorded in the 2 h after all meals over the 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411289     DOI: 10.3109/00365529209011187

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

1.  Causal relationship between delayed gastric emptying and gastroesophageal reflux in patients with neurological impairment.

Authors:  Hisayoshi Kawahara; Yuko Tazuke; Hideki Soh; Noriaki Usui; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2015-08-15       Impact factor: 1.827

2.  Ultrasonographic study of postcibal gastro-esophageal reflux and gastric emptying in infants with recurrent respiratory disease.

Authors:  Agostino Di Ciaula; Piero Portincasa; Leonardo Di Terlizzi; Domenico Paternostro; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Diagnosis and treatment of gastroesophageal reflux disease in infants and children.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

4.  Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.

Authors:  T Takeda; H Konomi; G Naritomi; J Yoshida; H Matsunaga; K Akazawa; M Tanaka
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

5.  Randomised controlled trial of cisapride in preterm infants.

Authors:  R J McClure; J H Kristensen; A Grauaug
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 6.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Gastroesophageal reflux and gastric emptying, revisited.

Authors:  Sara Emerenziani; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2005-06

8.  Randomised controlled trial of cisapride in feed intolerance in preterm infants.

Authors:  A Enriquez; S Bolisetty; S Patole; P A Garvey; P J Campbell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

Review 9.  A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors:  J Tack; G Coremans; J Janssens
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 10.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.